Drug Approval | January 14, 2022
U.S. FDA approves treatment to control pain in cats with osteoarthritis
It is the first monoclonal antibody drug for use in any animal species
It is the first monoclonal antibody drug for use in any animal species
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
Systemic Lupus Erythematosus, or Lupus, is an autoimmune chronic inflammatory disease. The prevalence of SLE in the U.S. has been reported to be between 20 to 150 cases per 100,000. In India, the reported prevalence of SLE is 3.2 per 100,000
The current round is led by IIFL Asset Management (IIFL AMC) along with investment from existing investors InvestCorp and Bessemer Venture Partners (BVP)
The group now has 325 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.
According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron
The hospital is scheduled to open in 2024 with a bed capacity of 225
The product will be commercialized from Unichem's Ghaziabad plant
The week-long campaign received a record 17.691 pledges
The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis
Subscribe To Our Newsletter & Stay Updated
